# Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis

> **NCT00571701** · PHASE2 · COMPLETED · sponsor: **Northwell Health** · enrollment: 50 (actual)

## Conditions studied

- Recurrent Respiratory Papillomatosis

## Interventions

- **DRUG:** celebrex (celecoxib)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00571701
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571701, "Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00571701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*